Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001324352-05-000001
Filing Date
2005-04-28
Accepted
2005-04-28 11:59:12
Documents
1
Period of Report
2003-11-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2728
  Complete submission text file 0001324352-05-000001.txt   4527
Mailing Address 100 TRI STATE INTERNATIONAL SUITE 100 LINCOLNSHIRE IL 60069
Business Address 2500 MILLBROOK DRIVE BUFFALO GROVE IL 60089 8472796100
AKORN INC (Issuer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2500 MILLBROOK DRIVE BUFFALO GROVE IL 60089
Business Address 847-279-6100
Stern John W (Reporting) CIK: 0001324352 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32360 | Film No.: 05779142